SWOG clinical trial number
SWOG-7963

m-AMSA in Melanoma, Myeloma, Lymphoma, Oat Cell Lung Carcinoma and Breast Cancer

Closed
Phase
Abbreviated Title
m-AMSA in Melanoma, Myeloma, Lymphoma, Oat Cell Lung Carcinoma and Breast Cancer
Activated
04/20/1979
Closed
04/05/1982

Publication Information Expand/Collapse

1983

Phase II evaluation of Amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: A University of Arizona and Southwest Oncology Group study

FR Ahmann;F Meyskens Jr;SE Jones;RM Bukowski;JH Saiers;DH Ryan;J Costanzi;CB Vaughn;CA Coltman Jr Cancer Treat Rep 67:697-700

1980

A broad Phase II trial of AMSA with in vitro stem cell culture drug sensitivity correlation

F Ahmann;F Meyskens;S Jones;B Durie;D Alberts;S Salmon ASCO #C-199